EQL Pharma AB's market cap is currently €162.02M. The company's EPS TTM is €0.030753000000000003; its P/E ratio is 40.22; EQL Pharma AB is scheduled to report earnings on August 19, 2025, and the estimated EPS forecast is €0.04. See an overview of income statement, balance sheet, and cash flow financials.
